novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Weight-Loss Drug Lowers Major Heart Disease By 20%, Trial Says—Novo Nordisk Shares Surge Novo Nordisk's oral Wegovy reduces

The main contraindications for semaglutide are: Having a personal or family history of medullary thyroid cancer (MTC)

As appetite decreases, many users naturally shift toward: Smaller meals Higher protein intake More hydration awareness Structured nutrition habits Many healthcare providers encourage GLP-1 users to aim for roughly 80120 grams of protein per day, although individual needs vary based on body size, activity level, age, and overall goals

Reduced appetite suppression or a weaker sense of fullness after injection can indicate the medication's potency has declined, though this can also reflect individual variation or tolerance development

Morning dosing works if breakfast is your primary meal or if evening injections cause sleep disruption

All cellular activities stop after the lesion reaches a certain size when senescence is triggered

Jones LL, McDonald DA, Borum PR